"Analogous to our work at CNS Response, CORE's unique database allowed vastly improved management of medical disability for large employers and payors. That background should help in our mission to improve management of behavioral healthcare, particularly with employers and payors," commented Horace Hertz, CFO of CNS Response.
Mr. Carpenter, President of CNS Response, remarked, "I have commercialized a number of technologies in health care, but have never seen such a potentially industry-changing opportunity. The implications of a technology that helps doctors prescribe the right medication for the right patients, even the most treatment-resistant, are enormous for patients, providers and payors. I look forward to working with Len and his team to make this happen."
About CNS Response
CNS Response is a life-sciences data company focused on the commercialization of the first patented commercial system that guides psychiatrists and other physicians to determine proper treatments for patients with behavioral (mental or addictive) disorders. This technology allows CNS Response to create and provide simple reports ("rEEG(SM) Reports") that specifically guide physicians to treatment strategies based on the patient's own physiology.
rEEG(SM) utilizes traditional electroencephalography (EEG) in
conjunction with a normative database and a proprietary clinical
(symptomatic) database to identify the following: (1) medication classes
most likely to be needed; and (2) medications within these classes with the
most probable treatment potential for each patient. Reports are provided to
physicians in a relationship analogous to that of a reference laboratory.
Prospective, retrospective and field studies of treatment-resistant
patients have reported treatment success of 70% or greater in managed care,
outpatient psychiatric and re
'/>"/>
| SOURCE CNS Response, Inc. Copyright©2007 PR Newswire. All rights reserved |